Literature DB >> 32193639

Differences in the clinical management of women and men after detection of a solitary pulmonary nodule in clinical practice.

Elisa Chilet-Rosell1,2, Lucy A Parker3,4, Ildefonso Hernández-Aguado3,4, María Pastor-Valero3,4, José Vilar5, Isabel González-Álvarez6, José María Salinas-Serrano7, Fermina Lorente-Fernández6, M Luisa Domingo5, Blanca Lumbreras3,4.   

Abstract

OBJECTIVES: To explore differences in the clinical management of men and women in the 5 years after detecting a solitary pulmonary nodule (SPN) by chest radiograph or CT in routine clinical practice.
METHODS: We followed up 545 men and 347 women with an SPN detected by chest radiograph or CT in a retrospective cohort of 25,422 individuals undergoing routine thoracic imaging in 2010-2011. We compared the frequency of each management strategy (no further test, immediate intervention or follow up) according to sex by means of chi-squared. We estimated the relative risk of women versus men of having been followed up instead of an immediate intervention using multivariate logistic regression. We compared by sex the time between detection of the nodule and lung cancer diagnosis, the time between diagnosis and death by means of Mann-Whitney U test and the cumulative effective dose of radiation in each management strategy by means of t test.
RESULTS: Women were more likely than men to have follow-up rather than immediate intervention (aRR = 1.8, CI 1.3-2.7, p = 0.002), particularly in those who underwent CT (aRR = 4.2, CI 1.9-9.3, p < 0.001). The median time between SPN detection and lung cancer diagnosis was higher in women (4.2 months, interquartile range (IQR) 5.1) than in men (1.5 months, IQR 16.2). The mean cumulative effective dose was 21.3 mSv, 19.4 mSv in men and 23.9mv in women (p = 0.023).
CONCLUSIONS: Our results could reflect decisions based on a greater suspicion of lung cancer in men. The incidental detection of SPNs is increasing, and it is necessary to establish clear strategies aimed to reduce variability in their management according to patient's sex. KEY POINTS: • After incidental finding of SPN, women were less likely to receive an immediate intervention. • Accumulative radiation was higher in women than in men. • Our results could reflect decisions based on a greater suspicion of lung cancer in men.

Entities:  

Keywords:  Lung cancer; Sex differences; Solitary pulmonary nodule

Mesh:

Year:  2020        PMID: 32193639     DOI: 10.1007/s00330-020-06791-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Diagnostic delay causes more psychological distress in female than in male cancer patients.

Authors:  T Risberg; S W Sørbye; J Norum; E A Wist
Journal:  Anticancer Res       Date:  1996 Mar-Apr       Impact factor: 2.480

2.  A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokers.

Authors:  Stephanie A Kovalchik; Sara De Matteis; Maria Teresa Landi; Neil E Caporaso; Ravi Varadhan; Dario Consonni; Andrew W Bergen; Hormuzd A Katki; Sholom Wacholder
Journal:  BMC Med Res Methodol       Date:  2013-11-19       Impact factor: 4.615

3.  The Fate of Patients with Solitary Pulmonary Nodules: Clinical Management and Radiation Exposure Associated.

Authors:  Blanca Lumbreras; José Vilar; Isabel González-Álvarez; Noemí Gómez-Sáez; María L Domingo; María F Lorente; María Pastor-Valero; Ildefonso Hernández-Aguado
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

  3 in total
  2 in total

1.  Multivariate Analysis on Development of Lung Adenocarcinoma Lesion from Solitary Pulmonary Nodule.

Authors:  Linxiang Yu; Bin Zhang; Haosheng Zou; Yi Shi; Liang Cheng; Ying Zhang; Haiwen Zhen
Journal:  Contrast Media Mol Imaging       Date:  2022-05-24       Impact factor: 3.009

2.  Solitary pulmonary nodule malignancy predictive models applicable to routine clinical practice: a systematic review.

Authors:  Marina Senent-Valero; Julián Librero; María Pastor-Valero
Journal:  Syst Rev       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.